Actively Recruiting

All Genders
ID01166009

Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Led by Center for International Blood and Marrow Transplant Research · Updated on 2025-08-12

99999999

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are gathering comprehensive observational data on hematopoietic stem cell (HSC) transplantation, other cellular therapies, and marrow toxic injuries to better understand these treatments and their outcomes. The study aims to learn what factors contribute to successful stem cell transplants and cellular therapies, including patient recovery, genetic influences, and access to treatments. It also seeks to improve donor recovery after collection procedures and study marrow toxic injuries comprehensively. This is an observational research database without specific treatments or interventions assigned to participants. It includes recipients of unrelated, related donor, or autologous HSC transplants, individuals treated for marrow toxic injuries, and donors registered on the National Marrow Donor Program (NMDP) Registry. Data collection is ongoing and does not direct clinical care or treatment choices. Participants contribute data through their involvement in transplant centers or treatment programs, and information is collected annually to assess outcomes like stem cell transplant recovery and marrow toxic injury status. The study monitors recipients, donors, and individuals with marrow toxic injuries over time, gathering detailed observational data to support future research. Participation duration varies as data are collected continuously from multiple sources.

CONDITIONS

Brief Title

CIBMTR Research Database

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Recipient of an unrelated or related donor or autologous hematopoietic stem cell transplant at a participating center
  • Adults and children with or without decision-making capacity
  • Individuals treated for marrow toxic injury at a center in the Radiation Injury Transplant Network
  • Eligible individuals may have received supportive care, growth factor support, transplant, or other medical treatments for marrow toxic injury
  • All donors registered on the National Marrow Donor Program Registry who have been requested to donate
  • Maternal cord blood donors enrolled in the Cord Blood Bank Investigational New Drug protocol with signed informed consent
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Long-term Monitoring

Duration - Up to several years

Participants who undergo routine care are observed with annual assessments to collect comprehensive data on hematopoietic stem cell transplantation and marrow toxic injuries.

Annual visits

Trial Site Locations

Total: 2 locations

1

Center for International Blood and Marrow Transplant Research

Minneapolis, Minnesota, United States, 55413

Actively Recruiting

2

Medical College of Wisconsin

Milwaukee, Wisconsin, United States, 53226

Actively Recruiting

Loading map...

Research Team

L

Leigh Anne Blackmon

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A First-in-Human, Open-Label, Dose Escalation and Expansion ...

Solid Tumors

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study.

Ehab Atallah, Brent Logan, Min Chen...

https://pubmed.ncbi.nlm.nih.gov/31830234